/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Dr. Alexander Lyon is a Consultant Cardiologist at the Royal Brompton Hospital.
Alex studied medicine at Oxford University where he gained a first class degree, and studied for his PhD thesis in myocardial gene therapy at Imperial College London. His clinical interests are in the field of heart failure, cardio-oncology and the cardiovascular complications of modern cancer therapies, Takotsubo syndrome, and the development of novel therapeutics including gene therapy for chronic heart failure.
Alex was co-chair of the ESC 2022 guideline on cardio-oncology.
Alex is chair of the ESC Cardio-Oncology Council (2022-2024) and past-president of the British Cardio-Oncology Society.
Alex is a deputy editor of the European Heart Journal (Cardio-Oncology team).
Alex was previously a board member of the Heart Failure Association of the European Society of Cardiology from 2016-2020, where he was chair of the HFA study groups for Cardio-Oncology and Takotsubo Syndrome.
